LifeSci Capital Reiterates a Buy on Olema Pharmaceuticals (OLMA)

​Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) is one of the Best Small Cap Stocks Ready to Explode in 2026. On January 26, Sam Slutsky from LifeSci Capital reiterated a Buy rating on the stock and raised the price target from $39 to $45. Earlier, on January 14, Kelsey Goodwin from Piper Sandler reiterated a Buy rating on Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) with a price target of $40. ​Analysts at Piper Sandler noted that the bullish rating is based on the company’s Palazestrant. Palazestrant is a pote ...